Konu "ranibizumab" için Fakülteler / Faculties listeleme
Toplam kayıt 4, listelenen: 1-4
-
Choroidal Thickness After Dexamethasone Implant or Aflibercept in Patients with Diabetic Macular Edema Persistent to Ranibizumab
(2020)Purpose: This study aims to compare subfoveal choroidal thicknesses (SFCTs) after intravitreal dexamethasone (IVD) or intravitreal aflibercept (IVA) treatment in patients with persistent diabetic macular edema (DME) ... -
Choroidal thickness measurements with optical coherence tomography in branch retinal vein occlusion
(2016)AIM: To evaluate central macular thickness (CMT) and mean choroidal thickness (MCT) in eyes with branch retinal vein occlusion (BRVO), before and after ranibizumab treatment using spectral domain -optical coherence tomography ... -
Favorable outcomes in the treatment of aggressive posterior retinopathy of prematurity
(2019)Objectives: To report the results of intravitreal ranibizumab injection as primary therapy in aggressive posterior retinopathy of prematurity, the process of the disease, and the additive treatments performed. Methods: ... -
Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis
(2014)Purpose: To describe 1-year clinical results of intravitreal ranibizumab treatment in patients with choroidal neovascularization secondary to exudative age-related macular degeneration (AMD) and to evaluate whether early ...